openPR Logo
Press release

Advancing Healthcare: Molecular Diagnostics Market Driven by Innovation and Personalized Medicine

11-28-2024 10:15 AM CET | Health & Medicine

Press release from: Mordor Intelligence

Molecular Diagnostics Market Size

Molecular Diagnostics Market Size

Mordor Intelligence has published a new report on the Molecular Diagnostics Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The global molecular diagnostics market is anticipated to grow significantly, from USD 13 billion in 2024 to USD 20 billion by 2029, at a robust CAGR of 9.22%. The rising prevalence of infectious diseases, advancements in diagnostic technologies, and growing emphasis on personalized medicine are driving this growth. Key technologies like Polymerase Chain Reaction (PCR) and next-generation sequencing (NGS) are reshaping the diagnostics landscape, offering precise, rapid, and reliable solutions for various applications including oncology and infectious disease detection.

Report Overview: https://www.mordorintelligence.com/industry-reports/molecular-diagnostics-market

Key Trends

1. Increasing Prevalence of Infectious Diseases

The rising incidence of infectious diseases, such as COVID-19, tuberculosis, and influenza, has driven demand for molecular diagnostic tools:

These tools provide rapid, accurate pathogen identification, critical for timely treatment decisions.

Molecular diagnostics were pivotal during the COVID-19 pandemic, enabling mass testing and tracking of virus variants.

2. Expansion of Point-of-Care Diagnostics

Point-of-care (POC) diagnostics are revolutionizing healthcare by offering fast and accessible testing solutions:

POC molecular tests for tuberculosis, influenza, and other pathogens are gaining traction in primary care settings.

The affordability and efficiency of POC diagnostics make them a preferred choice for chronic disease management and early disease detection.

3. Advancements in Technology and Pharmacogenomics

Technological breakthroughs are driving the molecular diagnostics market forward:

Innovations in PCR, NGS, and biosensors enhance the speed and accuracy of diagnostics.

Pharmacogenomics, a cornerstone of personalized medicine, is leveraging molecular diagnostics for tailored treatments, supported by significant investments from governments and private sectors.

4. Rising Focus on Oncology and Genetic Testing

Molecular diagnostics play a critical role in cancer detection and genetic disease screening:

Early detection through liquid biopsies and other advanced tools improves patient outcomes.

Increasing adoption of molecular diagnostics in genetic testing aids in identifying hereditary diseases and planning preventive interventions.

Market Segmentation

The molecular diagnostics market is segmented by Technology, Application, Product, End User, and Geography:

By Technology:

PCR: Dominates the market due to its unmatched sensitivity and specificity.

Sequencing: Gaining traction for advanced applications like oncology and genetic research.

Other Technologies: Includes in situ hybridization, microarrays, and mass spectrometry.

By Application:

Infectious Disease Diagnostics: Largest segment, driven by high demand for pathogen detection.

Oncology: Expanding due to increasing focus on cancer diagnostics.

Genetic Testing: Growing use in prenatal and hereditary disease screening.

Other Applications: Includes pharmacogenomics and microbiology.

By Product:

Instruments: Advanced diagnostic devices for hospitals and laboratories.

Reagents and Consumables: Essential for test accuracy and reliability.

Other Products: Software and systems supporting diagnostics.

By End User:

Hospitals: Largest end-user segment, driven by integration of diagnostic tools into routine care.

Laboratories: High adoption of advanced molecular techniques for specialized testing.

Other End Users: Includes research institutes and outpatient clinics.

By Geography:

North America: Largest market due to technological advancements and strong healthcare infrastructure.

Asia-Pacific: Fastest-growing region, with improving healthcare access and rising disease burden.

Europe: Significant growth due to increasing adoption of molecular diagnostics in cancer and infectious disease management.

Middle East & Africa, South America: Emerging markets with growing investments in healthcare systems.

Get a Customized Report Tailored to Your Requirements- https://www.mordorintelligence.com/market-analysis/molecular-diagnostic-devices

Key Players

Leading companies in the molecular diagnostics market are driving innovation and market expansion through strategic collaborations and technological advancements. Major players include Hologic, Inc, Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, and QIAGEN.

Hologic, Inc.: is an American medical technology company specializing in women's health, offering diagnostic, surgical, and medical imaging solutions.

Thermo Fisher Scientific: Known for its broad portfolio of molecular diagnostic tools, including reagents and consumables.

Abbott Laboratories: Offers advanced diagnostic instruments and POC solutions for various applications.

Danaher Corporation: Innovates in biosensors and genetic testing technologies.

QIAGEN: Pioneering personalized medicine with its molecular diagnostic solutions.

These companies are investing in R&D and forming partnerships to strengthen their market presence and meet evolving healthcare needs.

Conclusion

The molecular diagnostics market is poised for substantial growth, driven by advancements in technology, rising demand for personalized medicine, and the increasing prevalence of infectious diseases. Innovations in PCR and sequencing are reshaping diagnostics, enabling precise and rapid detection across various applications. While North America leads the market, Asia-Pacific is emerging as a significant growth hub due to improving healthcare infrastructure and rising disease burden. With major players focusing on innovation and strategic initiatives, the molecular diagnostics market is well-positioned to play a pivotal role in the future of healthcare.

Industry Related Reports

PCR Molecular Diagnostics Market: The PCR Molecular Diagnostics Market Report is segmented by Product Type (Instruments, Reagents and Consumables, and Software), Application (Infectious Disease Testing, Oncology Testing, and Other Applications), End Users (Hospitals, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).

To know more visit this link: https://www.mordorintelligence.com/industry-reports/pcr-molecular-diagnostics

Europe Molecular Diagnostics Market: The Europe Molecular Diagnostics Market Report is segmented by Technology (In Situ Hybridization, Chips and Microarrays, Mass Spectrometry (MS), Sequencing, PCR, and Other Technologies), Application (Infectious Diseases, Oncology, Pharmacogenomics, Microbiology, Genetic Disease Testing, and Other Applications), Product (Instruments, Reagents, and Other Products), End User (Hospitals, Laboratories, and Other End Users), and Geography (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe).

To know more visit this link: https://www.mordorintelligence.com/industry-reports/europe-molecular-diagnostics-market

North America Molecular Diagnostics Market: The North America Molecular Diagnostics Market Report provides insights into leading companies and is segmented by Technology (In-situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, PCR, and Other Technologies), Application (Infectious Disease, Oncology, Pharmacogenomics, Microbiology, Genetic Disease Screening, Human Leukocyte Antigen Typing, and Blood Screening), Product (Instruments, Reagents, and Other Products), End User (Hospitals, Laboratories, and Other End Users), and Geography (United States, Canada, and Mexico).

To know more about visit this link: https://www.mordorintelligence.com/industry-reports/north-american-molecular-diagnostics-market-industry

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Advancing Healthcare: Molecular Diagnostics Market Driven by Innovation and Personalized Medicine here

News-ID: 3761359 • Views:

More Releases for Diagnostic

Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects. Tenet Diagnostics got its NABL certification in the fastest time and is
Global Tissue Diagnostic Market 2020 Business Strategies – Roche Diagnostic, A …
The Zion Market Research added a new report “Tissue Diagnostic Market by Product Type (Consumables and Instruments), by Technology (Immunohistochemistry (IHC), in Situ Hybridization (ISH), Digital Pathology and Workflow Management, and Special Staining), by Diseases (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Others), and by End-users (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends
POC Cardiovascular Diagnostic Market Report 2018: Segmentation by Product (Diagn …
Global POC Cardiovascular Diagnostic market research report provides company profile for F. Hoffmann-La Roche, Siemens, Abbott, Biomerieux, Danaher and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on
Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users
Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening cervical infection, which in turn propels the demand for development of DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV
Diagnostic Imaging Services Market Trending Technologies and Company Overview 20 …
Diagnostic Imaging Services market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the